Cell & Gene Therapy

1. Accelerated LVV Manufacturing Enabled By Platform Excellence 11/25/2025

   Discover how a manufacturing platform enabled the rapid production of lentiviral vector in eight months. Learn the strategy used to balance speed, risk mitigation, and the highest quality standards.

2. Green Chemistry: Inherently Safer Chemistry For Accident Prevention 11/12/2025

   Chemical manufacturing must prioritize inherently safer substances to prevent accidents. Adopting greener alternatives improves worker health, lowers costs, and leads to safer products.

3. Green Chemistry: Catalysis – Use Catalysts, Not Stoichiometric Reagents 11/12/2025

   True green chemistry minimizes waste and maximizes effectiveness. Catalysis is a key technology for reducing the E-factor and increasing efficiency across industrial and biological synthesis.

4. The Principles Of Green Chemistry: Design For Energy Efficiency 11/11/2025

   Focusing on solvent management is key to minimizing energy consumption in synthesis. By reducing or replacing solvents, chemists significantly cut both hazardous waste and process energy use.

5. Gene Therapy Services 9/18/2025

   Fast-track your Gene Therapies from cutting-edge process development to commercial success with advanced viral vector manufacturing solutions!

6. Generation Of A Universal AAV Packaging Cell Line For Commercial Gene Therapy Manufacturing 9/4/2025

   Uncover the benefits of this CGMP-ready, stable AAV packaging cell line with proven expertise to reduce costs, streamline manufacturing, and make life-changing gene therapies more accessible to patients in need.

7. Development Of A Serotype-Agnostic AAV Platform For Suspension Cell Culture 9/4/2025

   To evaluate performance, we compared a suspension process with an adherent iCELLis (200 m²) system, assessing upstream and downstream recovery, as well as analytics using an AAV testing platform.

8. Lentiviral Vectors: The Key To Cell And Gene Therapy Success 7/30/2025

   Lentiviral vector manufacturing is complex and highly regulated, which is why a specialized CDMO is required to ensure safe, scalable, and compliant production from early development to commercialization.

9. AAV Viral Titering Using Nanoplate-Based Digital PCR 7/22/2025

   Examine how nanoplate-based digital PCR streamlines AAV titering, providing faster results and greater accuracy, advancing gene therapy development from the lab to the clinic.

10. SK pharmteco Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

    Our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.